Rubicon Research Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: RUBICON BSE: 544578

About Rubicon Research Limited

Rubicon Research is an Indian pharmaceutical company located in Mumbai.

Source: Wikipedia

Key facts

BSE symbol544578
NSE symbolRUBICON
ISININE506V01022
CINL73100MH1999PLC119744
Listing date16 Oct 2025
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorBNP & Associates (Sujata Chattopadhyay)
Registered officeMedOne House, B-75, Road No. 33, Wagle Estate, Thane (W), Maharashtra - 400 604, India
Index memberships

Financial performance

Full financials →
Fiscal yearMar 26
Total income (before exceptional items)—
Net profit188

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Parag Suganchand SanchetiExecutive DirectorJune 30, 2026
Pratibha Sudhir PilgaonkarExecutive DirectorJune 30, 2026
CHANGAVALLI VENKATIndependent DirectorJune 30, 2026
Kumarapuram Gopalakrishnan AnanthakrishnanIndependent DirectorJune 30, 2026
Milind Anil PatilIndependent DirectorJune 30, 2026
Pradnya Nandakumar SaravadeIndependent DirectorJune 30, 2026
Shantanu RasgotiNon-Executive DirectorJune 30, 2026
Varun TalukdarNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.